Literature DB >> 11395846

Symptomatology of anemia.

H Ludwig1, K Strasser.   

Abstract

The symptoms and severity of anemia depend on various factors, including the degree of anemia, the rapidity of its onset, and the age and physiologic status of the patient. Although the human body tries to counterbalance the effects of anemia by various mechanisms, almost every organ system of the human body is eventually affected. The symptoms experienced by patients vary from cold skin, dizziness, and palpitations to pulmonary edema, heart failure, depression, and severe impairment of cognitive function. Anemia substantially impacts patients' quality of life, a fact that has been shown in several clinical trials in patients with renal disease as well as in patients suffering from various malignancies undergoing chemotherapy. These studies evaluated the administration of recombinant human erythropoietin (r-HuEPO, epoetin alfa) to anemic patients, and it was shown that raising hemoglobin levels with epoetin alfa ameliorated the symptoms of anemia and significantly improved the functional status and overall quality of life in cancer patients. Furthermore, preliminary data indicate that the correction of anemia in cancer patients may in addition improve treatment efficacy and possibly overall survival. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395846     DOI: 10.1016/s0093-7754(01)90206-4

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  44 in total

1.  Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.

Authors:  Jean-Luc Canon; Johan Vansteenkiste; Michael Hedenus; Pere Gascon; Carsten Bokemeyer; Heinz Ludwig; Jan Vermorken; Jason Legg; Beatriz Pujol; Ken Bridges
Journal:  Med Oncol       Date:  2011-11-13       Impact factor: 3.064

2.  Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial.

Authors:  Maria E Cabanillas; Hagop Kantarjian; Deborah A Thomas; Gloria N Mattiuzzi; Michael E Rytting; Eduardo Bruera; Lianchun Xiao; B Nebiyou Bekele; Maria C Foudray; Jorge E Cortes
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

Review 3.  Onco-nephrology: an appraisal of the cancer and chronic kidney disease links.

Authors:  Hassan Izzedine; Mark A Perazella
Journal:  Nephrol Dial Transplant       Date:  2015-02-03       Impact factor: 5.992

4.  Impacts of anemia and transfusion on oncologic outcomes in patients undergoing surgery for colorectal cancer.

Authors:  Yoon-Hye Kwon; Han-Ki Lim; Min Jung Kim; Ji Won Park; Seung-Bum Ryoo; Seung-Yong Jeong; Kyu Joo Park
Journal:  Int J Colorectal Dis       Date:  2020-05-03       Impact factor: 2.571

5.  Development of a biomarker database toward performing disease classification and finding disease interrelations.

Authors:  Shaikh Farhad Hossain; Ming Huang; Naoaki Ono; Aki Morita; Shigehiko Kanaya; Md Altaf-Ul-Amin
Journal:  Database (Oxford)       Date:  2021-03-11       Impact factor: 3.451

Review 6.  Hypoxia and anaemia in patients with cancer of the uterine cervix.

Authors:  Francisco José Andreu-Martínez; Julia M Martínez-Mateu
Journal:  Clin Transl Oncol       Date:  2005-09       Impact factor: 3.405

7.  Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer.

Authors:  Silas C Martin; Dennis D Gagnon; Lucy Zhang; Carsten Bokemeyer; Marinus Van Marwijk Kooy; Ben van Hout
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 8.  Stimulating erythropoiesis in inflammatory bowel disease associated anemia.

Authors:  Georgia Tsiolakidou; Ioannis-E Koutroubakis
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 9.  Iron, anaemia, and inflammatory bowel diseases.

Authors:  C Gasche; M C E Lomer; I Cavill; G Weiss
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 10.  Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.

Authors:  David H Henry
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.